Drug Shortage Report for TOBI

Last updated on 2024-10-04 History
Report ID 192953
Drug Identification Number 02239630
Brand name TOBI
Common or Proper name TOBRAMYCIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 300MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 56 AMPULES
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-06-01
Actual start date 2023-05-31
Estimated end date 2024-10-01
Actual end date 2024-05-31
Shortage status Resolved
Updated date 2024-10-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2023-10-17 French Compare
v16 2023-10-17 English Compare
v15 2023-10-11 French Compare
v14 2023-10-11 English Compare
v13 2023-09-20 French Compare
v12 2023-09-20 English Compare
v11 2023-09-11 French Compare
v10 2023-09-11 English Compare
v9 2023-07-18 French Compare
v8 2023-07-18 English Compare
v7 2023-06-13 French Compare
v6 2023-06-13 English Compare
v5 2023-06-02 English Compare
v4 2023-05-31 French Compare
v3 2023-05-31 English Compare
v2 2023-05-24 French Compare
v1 2023-05-24 English Compare

Showing 41 to 57 of 57